Literature DB >> 8083189

Amino acids Lys-Asp-Asp-Lys-Pro-Val402 in the Ca(2+)-ATPase of cardiac sarcoplasmic reticulum are critical for functional association with phospholamban.

T Toyofuku1, K Kurzydlowski, M Tada, D H MacLennan.   

Abstract

Phospholamban interacts with SERCA2 (sarco/endoplasmic reticulum calcium ATPase isoform 2) but not SERCA3. The use of chimeric SERCA2/SERCA3 molecules has revealed that amino acids 336-412 in the phosphorylation domain of SERCA2 are essential for functional association with phospholamban (Toyofuku, T., Kurzydlowski, K., Tada, M., and MacLennan, D. H. (1993) J. Biol. Chem. 268, 2809-2815). When mutations were made in SERCA2 between amino acids 336 and 412 and the mutants were coexpressed with phospholamban, only mutation of amino acids Lys397 to Val402 affected phospholamban association with the Ca(2+)-ATPase. A chimeric Ca(2+)-ATPase, CH2, was created in which the phosphorylation domain of SERCA2 was replaced with that of SERCA3, disrupting functional interaction with phospholamban. The SERCA3 sequence QGEQLV402 was then mutated to the corresponding SERCA2 sequence, KDD-KPV402, and to the sequence KGEKPV402, resulting in restoration of functional interaction with phospholamban. Mutation to KGNKPV402 or to QGEQPV402 did not restore functional interaction with phospholamban. These results demonstrate that amino acids Lys397-Val402 comprise the interaction site with phospholamban in SERCA2, and probably also in SERCA1, and that the appropriate balance of charged and hydrophobic residues is an important feature of the interaction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083189

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Structure of Na+,K+-ATPase at 11-A resolution: comparison with Ca2+-ATPase in E1 and E2 states.

Authors:  W J Rice; H S Young; D W Martin; J R Sachs; D L Stokes
Journal:  Biophys J       Date:  2001-05       Impact factor: 4.033

2.  Kinetics studies of the cardiac Ca-ATPase expressed in Sf21 cells: new insights on Ca-ATPase regulation by phospholamban.

Authors:  J E Mahaney; J M Autry; L R Jones
Journal:  Biophys J       Date:  2000-03       Impact factor: 4.033

3.  Phospholamban domain IB forms an interaction site with the loop between transmembrane helices M6 and M7 of sarco(endo)plasmic reticulum Ca2+ ATPases.

Authors:  M Asahi; N M Green; K Kurzydlowski; M Tada; D H MacLennan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

Review 4.  Structural similarities of Na,K-ATPase and SERCA, the Ca(2+)-ATPase of the sarcoplasmic reticulum.

Authors:  K J Sweadner; C Donnet
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

Review 5.  What the structure of a calcium pump tells us about its mechanism.

Authors:  A G Lee; J M East
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

6.  Cytoplasmic interactions between phospholamban residues 1-20 and the calcium-activated ATPase of the sarcoplasmic reticulum.

Authors:  P Sharma; V B Patchell; Y Gao; J S Evans; B A Levine
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

7.  Computational design of a water-soluble analog of phospholamban.

Authors:  Avram M Slovic; Christopher M Summa; James D Lear; William F DeGrado
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

8.  Serca isoform expression in the mammalian retina.

Authors:  David Krizaj
Journal:  Exp Eye Res       Date:  2005-06-20       Impact factor: 3.467

9.  Structural constraints on the transmembrane and juxtamembrane regions of the phospholamban pentamer in membrane bilayers: Gln29 and Leu52.

Authors:  Wei Liu; Jeffrey Z Fei; Toru Kawakami; Steven O Smith
Journal:  Biochim Biophys Acta       Date:  2007-10-22

10.  Translation of Ser16 and Thr17 phosphorylation of phospholamban into Ca 2+-pump stimulation.

Authors:  W A Jackson; J Colyer
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.